The video discusses the Ebola virus, its spread, and the challenges in controlling it. It covers screening methods like infrared thermometers and PCR tests, highlighting their limitations. Treatment options such as convalescent serum and experimental drugs like Zmap are explored. The video also delves into vaccine development efforts by companies like GlaxoSmithKline and the Canadian government, emphasizing the urgency due to the outbreak's severity.

What is one major limitation of using infrared thermometers to screen travelers for Ebola?

• They can be easily fooled by medications like Tylenol.

• They can only detect Ebola in its final stages.

• They are too expensive to use widely.

• They require a blood sample to be effective.

Why is PCR testing considered more reliable than fever screening for Ebola?

• It is cheaper and faster.

• It can detect Ebola DNA even in asymptomatic patients.

• It does not require any specialized equipment.

• It has a 0% false negative rate.

What is a significant risk associated with using convalescent serum to treat Ebola?

• It requires genetic modification.

• It is ineffective in all cases.

• It can transmit other blood-borne diseases.

• It is only available in West Africa.

How is ZMapp, an experimental treatment for Ebola, produced?

• By extracting antibodies from recovered patients.

• By using plant-based proteins.

• By synthesizing the virus in a lab.

• By injecting mice with a protein from the Ebola virus.

What is the main reason the Canadian Ebola vaccine was not tested on humans earlier?

• It was not effective in primates.

• There was insufficient funding for trials.

• It was not approved by the World Health Organization.

• It was only effective in certain climates.

Which organization is collaborating with GlaxoSmithKline on an Ebola vaccine?

• Centers for Disease Control and Prevention

• Canadian Public Health Agency

• World Health Organization

• National Institutes of Health

What is the expected outcome if the large-scale human trial of the Ebola vaccine is successful?

• The vaccine will be available by April.

• The vaccine will be discontinued.

• The vaccine will be used only in the US.

• The vaccine will be tested on animals again.